algestone acetophenide has been researched along with medroxyprogesterone acetate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alba, VM; Alvarado, G; Bassol, S; Cravioto, MC; Garza-Flores, J; Hernandez, L; Perez-Palacios, G; Recio, R; Rivera, R | 1 |
| Toppozada, MK | 1 |
| Sang, GW | 1 |
| Koetsawang, S | 1 |
| Giwa-Osagie, OF | 1 |
4 review(s) available for algestone acetophenide and medroxyprogesterone acetate
| Article | Year |
|---|---|
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |
1 trial(s) available for algestone acetophenide and medroxyprogesterone acetate
| Article | Year |
|---|---|
Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Topics: Adult; Algestone Acetophenide; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Estradiol; Female; Humans; Injections; Intrauterine Devices, Copper; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prolactin; Random Allocation | 1989 |